AK-7,
420831-40-9,
3-(azepan-1-ylsulfonyl)-N-(3-bromophenyl)benzamide,
AK 7,
UNII-308B6B695N,
CHEMBL3222141,
308B6B695N,
C19H21BrN2O3S,
3-(1-azepanylsulfonyl)-N-(3-bromophenyl)benzamide,
3-(azepane-1-sulfonyl)-N-(3-bromophenyl)benzamide,
AC1LP8WE,
SIRT2 Inhibitor, AK-7,
Oprea1_876929,
MLS006011706,
SIRT2 Inhibitor II AK-7,
SCHEMBL1095726,
DTXSID30194926,
BCP09325,
ZINC1159030,
BDBM50008859,
MFCD03140195,
AKOS001632674,
Benzamide, N-(3-bromophenyl)-3-((hexahydro-1H-azepin-1-yl)sulfonyl)-,
CS-3223,
MCULE-6804773508,
NE52645,
AK-7, >=98% (HPLC),
NCGC00347936-01,
NCGC00347936-06,
BC600543,
HY-16691,
SMR004703433,
EU-0004902,
FT-0702786,
Y1898,
A12904,
AB00115363-01,
SR-01000432494,
SR-01000432494-1,
N-(3-Bromophenyl)-3-[(hexahydro-1H-azepin-1-yl)sulfonyl]benzamide,
N- (3- bromophenyl)- 3- [(hexahydro- 1H- azepin- 1- yl)sulfonyl]- benzamide,
ZINC01159030,
CID1328033,
B4713,